ClinicalMetric / Countries / Czech Republic / paroxysmal nocturnal hemoglobinuria pnh
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

paroxysmal nocturnal hemoglobinuria pnh Clinical Trials in Czech Republic

Active clinical trials for paroxysmal nocturnal hemoglobinuria pnh with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (1)

NCT04901936 Phase 2
Recruiting

A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Enrollment
12 pts
Country
🇨🇿 Czech Republic
Apellis Pharmaceuticals, Inc.
View Trial →

Frequently Asked Questions

How many paroxysmal nocturnal hemoglobinuria pnh clinical trials are active in Czech Republic?
There are currently 1 active clinical trials for paroxysmal nocturnal hemoglobinuria pnh with sites in Czech Republic, of which 1 are actively recruiting patients.
How can I join a paroxysmal nocturnal hemoglobinuria pnh clinical trial in Czech Republic?
To join a paroxysmal nocturnal hemoglobinuria pnh clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are paroxysmal nocturnal hemoglobinuria pnh trials in Czech Republic?
Active paroxysmal nocturnal hemoglobinuria pnh trials in Czech Republic span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global paroxysmal nocturnal hemoglobinuria pnh Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology